Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alcon, a Novartis Company
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must sign informed consent document;
Vision correctable to 0.1 (LogMAR) or better in each eye at distance with habitual lenses;
Manifest cylinder (at screening) less than or equal to 0.75 diopter (D) in each eye and spectacle add \<+0.50 D in each eye;
Current full-time wearer of spherical samfilcon A, comfilcon A, senofilcon C monthly or senofilcon A 2-week replacement lens within the power range of lens powers available;
Current user of an MPS (excluding OFPM) to care for lenses;
Willing to answer text messages on a daily basis during the study;
Willing to discontinue artificial tears during the study and rewetting drops on the days of study visits;
Use of digital devices (eg, smart phone, tablet, laptop or desktop computer) for 20 consecutive minutes at least twice a week and willing to continue for the duration of the study;
You may not be if
Habitual lens wear in an extended wear modality (routinely sleeping in lenses overnight for 1 or more nights per week);
Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear;
History of herpetic keratitis, corneal surgery or irregular cornea;
Prior refractive surgery;
Any use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
Currently using or have not discontinued Restasis®, Xiidra™ and/or topical steroids within the past 7 days;
Use of mechanical eyelid therapy or eyelid scrubs within 14 days before Visit 1 and not willing to discontinue during the study;
Monocular (only 1 eye with functional vision) or fit with only 1 lens;
Known pregnancy or lactating;
Clareo Health | Clinical Assessment of a HYDRAGLYDE® Regimen
